4.6 Article

17-Estradiol Abrogates Apoptosis Inhibiting PKC, JNK, and p66Shc Activation in C2C12 Cells

Journal

JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 116, Issue 7, Pages 1454-1465

Publisher

WILEY
DOI: 10.1002/jcb.25107

Keywords

17-ESTRADIOL; C2C12 MUSCLE CELLS; PKC; JNK; p66Shc

Funding

  1. Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 11220110100544]
  2. Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011-1871]

Ask authors/readers for more resources

17-Estradiol (E2) protects several non-reproductive tissues from apoptosis, including skeletal muscle. Previously, we showed that E2 at physiological concentrations prevented apoptosis induced by H2O2 in skeletal myoblasts. As we have also demonstrated a clear beneficial action of this hormone on skeletal muscle mitochondria, the present work further characterizes the signaling mechanisms modulated by E2 that are involved in mitochondria protection, which ultimately result in antiapoptosis. Here, we report that E2 through estrogen receptors (ERs) inhibited the H2O2-induced PKC and JNK activation, which results in the inhibition of phosphorylation and translocation to mitochondria of the adaptor protein p66Shc. In conjunction, the inhibition by the hormone of this H2O2-triggered signaling pathway results in protection of mitochondrial potential membrane. Our results provide basis for a putative mechanism by which E2 exerts beneficial effects on mitochondria, against oxidative stress, in skeletal muscle cells. J. Cell. Biochem. 116: 1454-1465, 2015. (c) 2015 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available